References
- ZhangXGuoJZhouYWuGThe roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cellsTissue Eng Part B Rev2014201849210.1089/ten.TEB.2013.020423758605
- CaloriGMAlbisettiWAgusAIoriSTagliabueLRisk factors contributing to fracture non-unionsInjury200738Suppl 2S11S18
- EinhornTAEnhancement of fracture-healingJ Bone Joint Surg Am19957769409567782368
- TzioupisCGiannoudisPVPrevalence of long-bone non-unionsInjury200738Suppl 2S3S9
- QuartoRMastrogiacomoMCanceddaRRepair of large bone defects with the use of autologous bone marrow stromal cellsN Engl J Med2001344538538610.1056/NEJM20010201344051611195802
- KumarPVinithaBFathimaGBone grafts in dentistryJ Pharm Bioallied Sci20135Suppl 1S125S12710.4103/0975-7406.11331223946565
- O’BrienFJBiomaterials & scaffolds for tissue engineeringMater Today2011143889510.1016/S1369-7021(11)70058-X
- WangZZhangDHuZMicroRNA-26a-modified adipose-derived stem cells incorporated with a porous hydroxyapatite scaffold improve the repair of bone defectsMol Med Rep20151233345335010.3892/mmr.2015.379525997460
- BiancoPRobeyPGStem cells in tissue engineeringNature2001414685911812110.1038/3510218111689957
- ZukPAZhuMMizunoHMultilineage cells from human adipose tissue: implications for cell-based therapiesTissue Eng20017221122810.1089/10763270130006285911304456
- FraserJKWulurIAlfonsoZHedrickMHFat tissue: an underappreciated source of stem cells for biotechnologyTrends Biotechnol200624415015410.1016/j.tibtech.2006.01.01016488036
- NakanishiCNagayaNOhnishiSGene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrowCirc J20117592260226821747191
- DmitrievaRIMinullinaIRBilibinaAATarasovaOVAnisimovSVZaritskeyAYBone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similaritiesCell Cycle201211237738310.4161/cc.11.2.1885822189711
- LeviBHyunJSNelsonERNonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repairStem Cells201129122018202910.1002/stem.75721997852
- SheynDPelledGZilbermanYNonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusionStem Cells20082641056106410.1634/stemcells.2007-085818218819
- MehrkensASaxerFGuvenSIntraoperative engineering of osteogenic grafts combining freshly harvested, human adipose-derived cells and physiological doses of bone morphogenetic protein-2Eur Cell Mater20122430831923018419
- ShiraishiTSumitaYWakamastuYNagaiKAsahinaIFormation of engineered bone with adipose stromal cells from buccal fat padJ Dent Res201291659259722538411
- PanettaNJGuptaDMLeeJKWanDCCommonsGWLongakerMTHuman adipose-derived stromal cells respond to and elaborate bone morphogenetic protein-2 during in vitro osteogenic differentiationPlast Reconstr Surg2010125248349320124834
- ShenQYuCGuoYHabitual tea consumption and risk of fracture in 0.5 million Chinese adults: a prospective cohort studyNutrients2018101110.3390/nu10111633.
- JohnellOGullbergBKanisJARisk factors for hip fracture in European women: the MEDOS study. Mediterranean osteoporosis studyJ Bone Miner Res199510111802181510.1002/jbmr.56501011258592959
- HegartyVMMayHMKhawKTTea drinking and bone mineral density in older womenAm J Clin Nutr2000711003100710.1093/ajcn/71.4.100310731510
- KhokharSVenemaDHollmanPCDekkerMJongenWA RP-HPLC method for the determination of tea catechinsCancer Lett19971141–21711729103282
- NicholsJAKatiyarSKSkin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanismsArch Dermatol Res20103022718310.1007/s00403-009-1001-319898857
- FujikiHSueokaEWatanabeTSuganumaMSynergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compoundsJ Cancer Res Clin Oncol201514191511152210.1007/s00432-014-1899-525544670
- RameshEElanchezhianRSakthivelMEpigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic dietFundam Clin Pharmacol200822327528410.1111/j.1472-8206.2008.00585.x18485145
- XuJZYeungSYChangQHuangYChenZYComparison of antioxidant activity and bioavailability of tea epicatechins with their epimersBr J Nutr200491687388110.1079/BJN2004113215182391
- MerelesDHunsteinWEpigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?Int J Mol Sci20111295592560310.3390/ijms1209559222016611
- ChenCHHoMLChangJKHungSHWangGJGreen tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell lineOsteoporos Int200516122039204510.1007/s00198-005-1995-016170444
- WeiYJTsaiKSLinLCCatechin stimulates osteogenesis by enhancing PP2A activity in human mesenchymal stem cellsOsteoporos Int20112251469147910.1007/s00198-010-1352-920683709
- LinJDella-FeraMABaileCAGreen tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytesObes Res200513698299010.1038/oby.2005.11515976140
- JinRShenMYuLWangXLinXAdipose-derived stem cells suppress inflammation induced by IL-1beta through down-regulation of P2X7R mediated by miR-373 in chondrocytes of osteoarthritisMol Cells201740322222910.14348/molcells.2017.231428343378
- LouGSongXYangFExosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinomaJ Hematol Oncol2015812210.1186/s13045-015-0220-726514126
- LiuYWuGde GrootKBiomimetic coatings for bone tissue engineering of critical-sized defectsJ R Soc Interface20107Suppl 5S631S64710.1098/rsif.2010.0115.focus20484228
- ZhangXJiangWLiuYHuman adipose-derived stem cells and simvastatin-functionalized biomimetic calcium phosphate to construct a novel tissue-engineered boneBiochem Biophys Res Commun201849511264127010.1016/j.bbrc.2017.11.15029175390
- KaidaKHondaYHashimotoYTanakaMBabaSApplication of green tea catechin for inducing the osteogenic differentiation of human dedifferentiated fat cells in vitroInt J Mol Sci20151612279882800010.3390/ijms16122608126602917
- ZengQLiXBeckGBalianGShenFHGrowth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stro-mal cells in vitroBone200740237438110.1016/j.bone.2006.09.02217070126
- KnippenbergMHelderMNZandieh DoulabiBWuismanPIKlein-NulendJOsteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cellsBiochem Biophys Res Commun2006342390290810.1016/j.bbrc.2006.02.05216500625
- Al-SalleehFBeattyMWReinhardtRAPetroTMCrouchLHuman osteogenic protein-1 induces osteogenic differentiation of adipose-derived stem cells harvested from miceArch Oral Biol2008531092893610.1016/j.archoralbio.2008.05.01418606395
- Sokolsky-PapkovMAgashiKOlayeAShakesheffKDombAJPolymer carriers for drug delivery in tissue engineeringAdv Drug Deliv Rev2007594–518720610.1016/j.addr.2007.04.00117540473
- YangCHLinCYYangJHLiouSYLiPCChienCTSupplementary catechins attenuate cooking-oil-fumes-induced oxidative stress in rat lungChin J Physiol200952315115919777801
- SugisawaAUmegakiKPhysiological concentrations of (-)-epigal-locatechin-3-O-gallate (EGCg) prevent chromosomal damage induced by reactive oxygen species in WIL2-NS cellsJ Nutr200213271836183910.1093/jn/132.7.183612097656
- YagiHTanJTuanRSPolyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cellsJ Cell Biochem201311451163117310.1002/jcb.2445923192437
- JinPWuHXuGZhengLZhaoJEpigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro studyCell Tissue Res2014356238139010.1007/s00441-014-1797-924682582
- ValiBRaoLGEl-SohemyAEpigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cellsJ Nutr Biochem200718534134710.1016/j.jnutbio.2006.06.00516963251
- JinPLiaoLLinXStimulating effect of a novel synthesized sulfonamido-based gallate ZXHA-TC on primary osteoblastsYonsei Med J201556376077110.3349/ymj.2015.56.3.76025837183
- OttoFThornellAPCromptonTCbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone developmentCell19978957657719182764
- KomoriTRegulation of bone development and maintenance by Runx2Front Biosci20081389890317981598
- LeeKSKimHJLiQLRunx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12Mol Cell Biol200020238783879211073979
- MaruyamaZYoshidaCAFuruichiTRunx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiencyDev Dyn200723671876189010.1002/dvdy.2118717497678
- LinLShenQWeiXComparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defectsCalcif Tissue Int2009851556510.1007/s00223-009-9250-x19424738
- LinYFJingWWuLIdentification of osteoadipo progenitor cells in fat tissueCell Prolif200841580381210.1111/j.1365-2184.2008.00542.x18616697
- FarmerSRTranscriptional control of adipocyte formationCell Metab20064426327310.1016/j.cmet.2006.07.00117011499
- SiersbaekRNielsenRMandrupSPPARgamma in adipocyte differentiation and metabolism – novel insights from genome-wide studiesFEBS Lett2010584153242324910.1016/j.febslet.2010.06.01020542036
- LinhartHGIshimura-OkaKDeMayoFC/EBPalpha is required for differentiation of white, but not brown, adipose tissueProc Natl Acad Sci U S A20019822125321253711606718
- RosenEDHsuCHWangXC/EBPalpha induces adipogenesis through PPARgamma: a unified pathwayGenes Dev2002161222610.1101/gad.94870211782441
- TangWSongHCaiWShenXReal time monitoring of inhibition of adipogenesis and angiogenesis by (-)-Epigallocatechin-3-gallate in 3T3-L1 adipocytes and human umbilical vein endothelial cellsNutrients20157108871888610.3390/nu710543726516907
- DarnellJEJrKerrIMStarkGRJak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteinsScience19942645164141514218197455
- DarnellJEJrSTATs and gene regulationScience19972775332163016359287210
- LevyDELeeCKWhat does Stat3 do?J Clin Invest200210991143114810.1172/JCI1565011994402
- NicolaidouVWongMMRedpathANMonocytes induce STAT3 activation in human mesenchymal stem cells to promote osteo-blast formationPLoS One201277e3987110.1371/journal.pone.003987122802946
- ParkGYoonBSMoonJHGreen tea polyphenol epigallocate-chin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathwayJ Invest Dermatol2008128102429244110.1038/jid.2008.10318463684
- MikamiYAsanoMHondaMJTakagiMBone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cellsJ Cell Physiol2010223112313310.1002/jcp.2201720039267
- PeruzziBCapparielloADel FattoreARucciNDe BenedettiFTetiAc-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signallingNat Commun2012363010.1038/ncomms165122252554
- ChipoyCBerreurMCouillaudSDownregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3J Bone Miner Res200419111850186110.1359/JBMR.04081715476586